@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-J9RLNBVW-F
  skos:prefLabel "Récepteur laminine"@fr, "Receptors, Laminin"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-X09D5715-7 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QS4SSZ7F-T
  skos:prefLabel "Récepteurs au collagène"@fr, "Receptors, Collagen"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-X09D5715-7 .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X09D5715-7
  skos:altLabel "Epiligrin Receptor"@en, "VLA-3"@en, "Gap b3"@en, "alpha3beta1 Epiligrin Receptor"@en, "Galactoprotein b3"@en, "Laminin-5 Receptor (alpha3beta1 integrin)"@en, "CD49c-CD29"@fr, "CD49c-CD29"@en, "Integrin alpha(3)beta(1)"@en, "Intégrine alpha3bêta1"@fr, "Intégrine alpha 3 bêta 1"@fr, "alpha3beta1 Integrin"@en ;
  mesh:allowableQualifier jvr:-N2WP45CN-V, jvr:-T2TS0S41-N, jvr:-H7K65Q8S-Z, jvr:-G7KXQWSR-5, jvr:-SBNWSM1T-R, jvr:-CJXMKG5Q-F, jvr:-FWD2BGQ0-9, jvr:-WZF2ZR3L-B, jvr:-W6SQV79N-S, jvr:-NHL3D2X0-S, jvr:-S0CS1X5R-5, jvr:-TJHVZCRZ-0, jvr:-R0ZCQ8X6-J, jvr:-Z9TSGBXH-4, jvr:-Q3979798-W, jvr:-L6C0XPHT-4, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-D0F21513-5 ;
  dc:created "2002-07-02"^^xsd:date ;
  dc:modified "2016-06-17"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  skos:broader jvr:-QS4SSZ7F-T, jvr:-J9RLNBVW-F, jvr:-K8VZ7GBS-8 ;
  dc:established "2003-01-01"^^xsd:date ;
  skos:prefLabel "Integrin alpha3beta1"@en, "Intégrine alpha3 bêta1"@fr ;
  skos:definition "Cell surface receptor for LAMININ, epiligrin, FIBRONECTINS, entactin, and COLLAGEN. Integrin alpha3beta1 is the major integrin present in EPITHELIAL CELLS, where it plays a role in the assembly of BASEMENT MEMBRANE as well as in cell migration, and may regulate the functions of other integrins. Two alternatively spliced isoforms of the alpha subunit (INTEGRIN ALPHA3), are differentially expressed in different cell types."@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D039201> ;
  skos:inScheme jvr: .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K8VZ7GBS-8
  skos:prefLabel "Récepteur VLA"@fr, "Receptors, Very Late Antigen"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-X09D5715-7 .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .